Win for Moms and Babies, 5th Circuit Restores Original FDA Safety Standards

Today, the U.S. 5th Circuit Court of Appeals agreed in-part with Texas Judge Matthew Kacsmaryk’s decision by returning to all the health and safety standards of mifepristone’s original approval in 2000.

Utilization of the abortion regimen will only be permitted with multiple in-person visits, and ultrasounds, affirming the dangers of mail-order abortion pills.

Sarah Zagorski, the Communications Director for Louisiana Right to Life, said the following about the decision: “Today’s decision confirms what we already know about the RU-486 abortion regimen. It is incredibly dangerous for women to consume these drugs without physician oversight. In fact, abortion-pill related emergency room visits has increased nearly 500% since the FDA removed the in-person dispensing requirement.”

She concluded, “At the expense of moms and babies, the FDA fast-tracked this drug by ignoring its own rules and science for their own benefit. We are thankful they are being held accountable. In Louisiana, because of our strong pro-life laws, these pills cannot be distributed at all, saving countless lives from abortion.”